Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NVO
NVO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NVO News
Japan Approves Wegovy for Liver Disease Treatment
11h ago
NASDAQ.COM
Novo Nordisk Launches CardioMetabolic Bridge to Advance Obesity Research
8h ago
Yahoo Finance
Zealand Pharma Shares Plunge 23% Amid Survodutide Concerns
20h ago
CNBC
Zealand Pharma Faces Setbacks, Analysts Reassess Obesity Drug Strategy
21h ago
Newsfilter
Hims & Hers Partners with Novo Nordisk, Boosting Stock Momentum
2d ago
stocktwits
Recap of CNBC Investing Club Monthly Meeting
2d ago
CNBC
Novo Nordisk to File for Wegovy Approval in China Soon
2d ago
seekingalpha
FDA Issues Warning Letters to Telehealth Firms Over Misleading GLP-1 Claims
2d ago
seekingalpha
Analysis of Weight Loss Drug Market Prospects
3d ago
Fool
Eli Lilly and Novo Nordisk Compete in Weight Loss Market
3d ago
NASDAQ.COM
Markets Pause as Investors Assess Latest Rally Amid Fed Meeting
3d ago
stocktwits
Three Innovative Biotechs with Promising Prospects
3d ago
NASDAQ.COM
Markets Pause as Investors Assess Latest Rally Amid Fed Meeting
3d ago
Yahoo Finance
Analysis of Three Promising Biotech Companies
3d ago
Fool
Eli Lilly: A Leader in the GLP-1 Market
5d ago
Fool
Reasons Investors Should Consider Eli Lilly Stock
5d ago
Yahoo Finance
Show More News
